戻る Agenda
Session 7: MERC Pharmacovigilance Session
Session Chair(s)
Reem K Al Essa, MBA
Coordination & Development Superintendent Pharmaceutical Services Administration, Ministry of Health, Kuwait
Hadir Rostom
Head, Egyptian Pharmaceutical Vigilance Center (EPVC), Pharmaceutical Affairs Central Administration (CAPA), Ministry of Health, Egypt, Egypt
Session 7: MERC Pharmacovigilance Session
Speaker(s)
Sean Burke, MSc
(EFPIA IPVG Representative) Pharmacovigilance Lead, EEMEA, Merck , United Kingdom
Phil Tregunno
Deputy Director - Patient Safety Monitoring, Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom
Shanthi Pal, DRSc, MPharm
Group Lead, Medicines Safety, Safety & Vigilance, WHO, Switzerland
The “Project 3-S”: Smart Safety Surveillance for priority medical products
Mohammed Ebrahim Fouda, PharmD, RPh
Head of Signal Detection Department, Saudi Food and Drug Authority (SFDA), Saudi Arabia
The SFDA Experience – Moving to the Investigation Phase
Reem K Al Essa, MBA
Coordination & Development Superintendent Pharmaceutical Services Administration, Ministry of Health, Kuwait
Kuwait’s Roadmap on Pharmacovigilance